Preprint Dissecting the genetic complexity of myalgic encephalomyelitis/chronic fatigue syndrome via deep learning-powered genome analysis, 2025, Zhang+

Discussion in 'ME/CFS research' started by SNT Gatchaman, Apr 17, 2025.

  1. forestglip

    forestglip Senior Member (Voting Rights)

    Messages:
    2,349
    I think it's possible that if their algorithm is working very differently from the method the Biobank used, the effect size wouldn't be large enough to cross the significance threshold.

    Another reason CFS might not have shown up but depression did could be that there are many more cases of depression in the Biobank which would increase statistical power. Using the Biobank search tool, I see 10 times as many depression cases as CFS cases:

    Chronic Fatigue Syndrome - 2,017 cases
    Depression - 26,114 cases
     
    ukxmrv, Jacob Richter, Lilas and 6 others like this.
  2. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    3,039
    Location:
    Norway
    This might be a silly question, but what happens if there is overlap in participants between the cohorts in genetic studies?

    Could you end up trying to validate your findings on a cohort that partially includes the people you first analysed?
     
    ukxmrv, Jacob Richter, MeSci and 4 others like this.
  3. V.R.T.

    V.R.T. Senior Member (Voting Rights)

    Messages:
    475
    On the subject of DecodeME, @Andy @Jonathan Edwards

    Can you provide any update on when DecodeME is due to publish? Or is it still 'as soon as it's ready and hopefully before August'?
     
  4. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    17,417
    Location:
    London, UK
    Something like that.
     
    Jacob Richter, MeSci, Saz94 and 7 others like this.
  5. Andy

    Andy Retired committee member

    Messages:
    23,820
    Location:
    Hampshire, UK
    Yep, exactly that.
     
    Jacob Richter, MeSci, Hutan and 6 others like this.
  6. Saz94

    Saz94 Senior Member (Voting Rights)

    Messages:
    3,674
    Location:
    UK
    What is Precision Life and what is Beentjes, please?
     
  7. Sasha

    Sasha Senior Member (Voting Rights)

    Messages:
    5,605
    Location:
    UK
    All one word, 'PrecisionLife' - here's a thread on it.
     
    Last edited: Apr 19, 2025
    Jacob Richter, Yann04, MeSci and 2 others like this.
  8. Saz94

    Saz94 Senior Member (Voting Rights)

    Messages:
    3,674
    Location:
    UK
    NAD as in the coenzyme Nicotinamide adenine dinucleotide, or are you referring to a gene called NAD?
     
    hotblack likes this.
  9. Saz94

    Saz94 Senior Member (Voting Rights)

    Messages:
    3,674
    Location:
    UK
    What's SequenceME? I have been fairly out of the loop.
     
  10. jnmaciuch

    jnmaciuch Senior Member (Voting Rights)

    Messages:
    770
    Location:
    USA
    I assume the former—NAMPT was one of the top genes identified, which is involved in an NAD production pathway
     
    ukxmrv, Kitty, MeSci and 3 others like this.
  11. Nightsong

    Nightsong Senior Member (Voting Rights)

    Messages:
    1,165
    ukxmrv, Jacob Richter, Ariel and 8 others like this.
  12. Sasha

    Sasha Senior Member (Voting Rights)

    Messages:
    5,605
    Location:
    UK
    Thread here.
     
    Jacob Richter, Saz94, Kitty and 3 others like this.
  13. Dolphin

    Dolphin Senior Member (Voting Rights)

    Messages:
    6,433
  14. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    17,417
    Location:
    London, UK
    The chat on this paper has died down. I remain puzzled. If they have have found evidence of genetic causation in ME/CFS this is a major milestone. If everyone is unsure whether the data are statistically robust then it would be nice to have a clear idea of why.

    There seems to be a problem that 'too many' gene sites have come up, making it unclear which to focus on. I wish I understood how this could happen. My intuition is that if we really think a gene is relevant then it will tell us something useful about mechanism. In the diseases I am familiar with the genetic links all make sense very easily - MHC Class I and II, PTPN22, common cytokine receptors, etc. It is such a pity that the presentation of this paper is so opaque.
     
    Jacob Richter, Ariel, ukxmrv and 11 others like this.
  15. Jacob Richter

    Jacob Richter Established Member (Voting Rights)

    Messages:
    70
    SequenceME is a collaboration between UoE, AfME and Oxford Nanopore Technologies which aims to conduct whole genome sequencing of 17,000 samples from the DecodeME sample set to look at every location in the 3 billion letter genome. This will go beyond the GWAS (i.e., DecodeME) by enabling identification of rare genetic variants and structural variations. More here: Oxford Nanopore, Action for ME, and University of Edinburgh launch groundbreaking study into the genetics of ME. A successful pilot phase has been completed and funding is actively being sought for the full study.
     
    Ariel, ukxmrv, Kitty and 5 others like this.
  16. Andy

    Andy Retired committee member

    Messages:
    23,820
    Location:
    Hampshire, UK
  17. Utsikt

    Utsikt Senior Member (Voting Rights)

    Messages:
    3,039
    Location:
    Norway
    @Jonathan Edwards would you be able to contact the authors?
     
  18. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,808
    Location:
    Aotearoa New Zealand
  19. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,808
    Location:
    Aotearoa New Zealand
    Just focusing on one of those, I've looked through my library for papers on neuroligin (Wikipedia) and spotted this paper that I'd squirrelled away from Jan 2024. It links neuroligin/neurexins (albeit NLGN3), autism, nitric oxide and gastrointestinal dysmotility. I've only read the abstract and it doesn't appear to have been cited thus far, but may be worth a read through the lens of ME.

    Faster Gastrointestinal Transit, Reduced Small Intestinal Smooth Muscle Tone and Dysmotility in the Nlgn3R451C Mouse Model of Autism
    Hosie, Suzanne; Abo-Shaban, Tanya; Mou, Kevin; Balasuriya, Gayathri K.; Mohsenipour, Mitra; Alamoudi, Mohammed U.; Filippone, Rhiannon T.; Belz, Gabrielle T.; Franks, Ashley E.; Bornstein, Joel C.; Nurgali, Kulmira; Hill-Yardin, Elisa L.

    Individuals with autism often experience gastrointestinal issues but the cause is unknown. Many gene mutations that modify neuronal synapse function are associated with autism and therefore may impact the enteric nervous system that regulates gastrointestinal function. A missense mutation in the Nlgn3 gene encoding the cell adhesion protein Neuroligin-3 was identified in two brothers with autism who both experienced severe gastrointestinal dysfunction.

    Mice expressing this mutation (Nlgn3R451C mice) are a well-studied preclinical model of autism and show autism-relevant characteristics, including impaired social interaction and communication, as well as repetitive behaviour. We previously showed colonic dysmotility in response to GABAergic inhibition and increased myenteric neuronal numbers in the small intestine in Nlgn3R451C mice bred on a mixed genetic background.

    Here, we show that gut dysfunction is a persistent phenotype of the Nlgn3 R451C mutation in mice backcrossed onto a C57BL/6 background. We report that Nlgn3R451C mice show a 30.9% faster gastrointestinal transit (p = 0.0004) in vivo and have 6% longer small intestines (p = 0.04) compared to wild-types due to a reduction in smooth muscle tone. In Nlgn3R451C mice, we observed a decrease in resting jejunal diameter (proximal jejunum: 10.6% decrease, p = 0.02; mid: 9.8%, p = 0.04; distal: 11.5%, p = 0.009) and neurally regulated dysmotility as well as shorter durations of contractile complexes (mid: 25.6% reduction in duration, p = 0.009; distal: 30.5%, p = 0.004) in the ileum. In Nlgn3R451C mouse colons, short contractions were inhibited to a greater extent (57.2% by the GABAA antagonist, gabazine, compared to 40.6% in wild-type mice (p = 0.007). The inhibition of nitric oxide synthesis decreased the frequency of contractile complexes in the jejunum (WT p = 0.0006, Nlgn3R451C p = 0.002), but not the ileum, in both wild-type and Nlgn3R451C mice.

    These findings demonstrate that changes in enteric nervous system function contribute to gastrointestinal dysmotility in mice expressing the autism-associated R451C missense mutation in the Neuroligin-3 protein.

    Link | PDF (International Journal of Molecular Sciences)
     
    Deanne NZ, Kitty, hotblack and 2 others like this.
  20. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights) Staff Member

    Messages:
    6,808
    Location:
    Aotearoa New Zealand
    Further on NLGN1, Genetic risk factors for severe and fatigue dominant long COVID and commonalities with ME/CFS identified by combinatorial analysis (2023, Journal of Translational Medicine) reported the following —

     

Share This Page